Article
Sodium channel blockers in the management of long QT syndrome: a system review and meta-analysis
2021-07-06
Abstract excerpt
<h4>Background: </h4> β-blockers are first-line therapy in patients with long QT syndrome (LQTS). However, β-blockers had genotype dependent efficacy (LQT1>LQT2>LQT3). Sodium channel blockers have been recommended as add-on therapy for LQT3 patients. However, the effect of sodium channel blockers in all LQT patients remains unknown. <h4>Methods:</h4> We conducted a systematic electronic search of PubMed, Embase an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6329ce1a-07c6-5114-a930-6b0904bef23a
- DOI
- 10.22541/au.162556418.83644601/v1
